NCT04112641: NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy
- State
- Under way
- Phase
- Phase 2
- People
- 48 planned
- Started
- 19 Feb 2020
- Primary completion
- 28 Jun 2027
- Arms
- Nicotinamide Riboside (NIAGEN)
- Results
- None posted
- 2 Oct 2019: Trial registered
- 19 Feb 2020: Trial started